Trialect

+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

Notice of Availability of Administrative Supplements for Research on Collaborative Projects with Indian Investigators on Low-Cost Medical Devices

National Institutes of Health

The purpose of this program is to encourage collaborative research and/or technology development between scientists and engineers in the United States and India. The National Institute of Biomedical Imaging and Bioengineering (NIBIB) announces the availability of administrative supplements for current NIBIB-supported research grants.

Supplements will be provided to develop appropriate diagnostic and therapeutic medical technologies for low-resource settings. Appropriate medical technologies are useable, cost effective, sustainable, and effective in meeting a significant clinical need in a low-resource setting. Collaborations should be aimed at developing medical technologies that can significantly impact underserved populations within the United States and/or India. Within this context grantees can apply for supplements to:

Develop variants of technologies presently being supported by an NIBIB research grant that are appropriate for low-resource settings;
Accelerate the translation of NIBIB-funded research and technology development for low-resource applications; and
Expand the potential applications of NIBIB funded research within low-resource settings.

The supplemental funds will support investigators based in the United States who are collaborating with Indian investigators. In addition, Indian collaborators are expected to apply to the Department of Biotechnology (DBT) in India, Dr. T. S. Rao (tsrao@dbt.nic.in), for complementary funding.

Specialties

Medical - Clinical Science

Engineering and Physical Sciences

Medical - Translational

Medical

Eligibility Requirements

Currently supported NIBIB R01, R21, U01, U54, U41, P01 and P41 awards may be supplemented. To be eligible, the parent NIBIB grant must have at least 12 months remaining at the time the supplement is awarded. The research proposed in the supplement application must be accomplished within the competitive segment.

Sponsor Details

Sponsor Institute/Organizations: National Institutes of Health

Sponsor Type:

Address: National Institutes of Health; 31 Center Drive; MSC 2220; Bethesda; MD 20892-2220; USA

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity